IOmx Therapeutics

Series A

Munich, GermanyFounded 2016Sep 2016

IOmx Therapeutics raised €40M in a Series A round in Sep 2016. The company is based in Munich, Germany. Investors in the round: Merck Ventures, MPM Capital, Sofinnova Partners and 1 other. Data as of Nov 2026.

← IOmx Therapeutics

Amount raised

€40M

€40,000,000

Native amount

40,000,000 EUR

Stage

Series A

series a

Investors

Provenance & confidence

Unverified

Amount

Reported in EUR — no conversion. €40M

High confidence

Source

No source on record — unverified.

Unverified

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

4 named

Merck Ventures MPM Capital Sofinnova Partners Wellington Partners

Date

Sep 2016

Round type

series a

Amount (EUR)

€40M

Other rounds

same company

2021-10Series B€65M